September 15, 2016
2 min watch
Save

VIDEO: Post hoc analysis of DRCR.net Protocol I

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

COPENHAGEN — At the Euretina meeting, Albert Augustin, MD, reports on the post hoc analysis of DRCR.net Protocol I data, evaluating ranibizumab against triamcinolone in patients with diabetic macular edema.